Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Tuesday November 17, 2009

DrStockPick.com Stock Report!

 

 

Crown Equity Holdings - CRWE has been trading on the quiet side lately but it looks like things are starting to heat up!

CRWE - Crown Equity Holdings, Inc has recently made some announcements regarding acquisitions that could have far reaching implications for CRWE short, medium and long term investors.

One acquisition involves DJ Toys and Yana, a toy manufacturer and a venture philanthropy group while the other involves TTNews of Taiwan, a news company. All companies are based in Taiwan with the exception of Crown

...

Neah Power Systems, Inc. today described its unique ability to utilize multiple fuel solutions to power methanol-powered fuel cells. The company’s porous silicon design allows for the use of a variety of oxidants and fuels, including oxygen, hydrogen peroxide, and nitric acid, while the anode loop has been run with several concentrations of methanol and formic acid for its fuel.

Danny Wilks, Research Scientist, Neah Power Systems, explained, “All electrochemical cells have two fundamental parts: an anode and a cathode. These electrodes act in much the same way as terminals in a battery. The anode catalyzes a fuel source such as methanol to harvest electrons that are then ‘donated’ to the reaction. The electrons are then transferred to the cathode where an oxidant is catalyzed to accept the donated electrons. The flow of electrons in this reaction is how electricity is generated in an electrochemical cell. On the anode loop,

...

Crown Equity Holdings, Inc. Entered Into Letter of Intent with DJ Toys and Yana

Las Vegas, Nevada – (CRWENEWSWIRE) November 13, 2009 – Crown Equity Holdings, Inc. (CRWE.OB) announced that it has entered into Letters of Intent to enter into business combinations with DJ Toys Enterprise Corporation and Yana Venture Philanthropy Group, both of which are Taiwan corporations.

“From a company standpoint, the acquisition of DJ Toys and Yana will result in our shareholders having stakes in additional profitable, operating companies,” stated Kenneth Bosket, CEO and President of Crown Equity Holdings, Inc. The companies are now beginning due diligence reviews and negotiating the terms of definitive, material agreements. Once the reviews are completed and terms agreed to, the parties will work to execute an agreement. The agreements are not expected to close until the first quarter of 2010.

...

Arrayit Diagnostics, a majority owned subsidiary of Arrayit Corporation, announced that the company will launch an intensive marketing campaign which will be the most aggressive one of its kind in their thirteen-year history. Arrayit Diagnostics is developing several diagnostic tests that will provide early detection for cancer and other deadly diseases which will provide incentive to the marketplace and comfort to families across the world.

The parent company, Arrayit Corporation, has rapidly become a leader in the genetic, pharmaceutical and diagnostic communities. While the company started in a small spectrum, Arrayit has blossomed into a major force which now offers over 650 products to a growing customer base of more than 10,000 laboratories across the globe. Arrayit Diagnostics has become the parent company’s shining star.

By conclusively identifying the genomic and proteomic biomakers for specific diseases, the tests conducted by Arrayit Diagnostics will enable early-stage diagnosis and will save

...

Neptune Technologies & Bioressources Inc. announced that the patent, “KRILL EXTRACTS FOR PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES,” was successfully issued in Europe, marking an integral achievement in eliminating competition of other entities focused on krill extract in the European cardiovascular market.

The issuance of the patent is expected to thwart unregulated marketing of krill oil and relative products.

“Recently, we observed players cheating on the market and misleading consumers by selling krill oil in Europe without any regulatory approval. We also noticed that they advertise unproven health benefits with their products as well as infringe on our patents. This was surprising until we realized who were involved. These situations will be addressed as required,” Henri Harland, CEO and president of Neptune stated in the press release.

The company also announced that the European Food Safety Authority (EFSA) signed the approval of Neptune Krill Oil as a Novel Food and

...

Wolverine World Wide Inc. (WWW) recently posted third-quarter earnings of 62 cents per share, eclipsing the Zacks Consensus Estimate by 11%. The company hiked its full-year earnings guidance, and analysts followed suit, lifting the Zacks Consensus Estimate to $1.74 per share from last month's $1.68. Shares spiked on the strong quarter, currently trading near a 52-week high.

Company Description

Wolverine World Wide markets branded casual, active lifestyle, work, outdoor sport and uniform footwear and apparel. The company offers well-known brands like Bates®, Chaco®, Cushe(TM), Hush Puppies®, HYTEST®, Merrell®, Sebago® Soft Style® and Wolverine®. Wolverine is also the exclusive footwear licensee of popular brands, including CAT®, Harley-Davidson® and Patagonia®. The company's products are sold retailers in the U.S. and globally in 180 countries and territories.

Stellar Quarterly Results and Bullish Forecasts

Wolverine World Wide recently posted third-quarter earnings of 62 cents per share, eclipsing the Zacks Consensus Estimate by 11%.

...

Bruce Weitzberg CEO and President of Patient Access Solutions, Inc. (OTCPK: PASO) stopped by SmallCapVoice.com to let the listeners know that his Company, Patient Access Solutions, Inc. (PAS) is a Healthcare Solutions Company which has created a formidable array of technology, resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare information technology environment. The Company’s products are designed to allow healthcare providers an easy migration of the EMR environment. Among these products are D-PAS, which is a state-of-the-art digital pen and paper technology based on Anoto technology, used to capture handwritten information into digital forms and EMR systems and PAS Data Center, which is a terminal solution that allows healthcare providers to quickly and easily determine benefit eligibility. More information on Patient Access Solutions, Inc. and its products can be viewed at www.pashealth.com.

...

Today, 310 Holdings, Inc. announced that it has changed its corporate name to JBI, Inc. The company will announce a symbol change when available. Despite a name change, JBI is still committed to investing its resources in long-term, highly sustainable growth and real value through its recently acquired subsidiaries.

JBI also announced that its unaudited, nine month consolidated pro-forma revenues totaled $10,156,919, with reported net earnings at $167,398. The company’s total assets valued at $22,486,751. Full financial details are available at www.sec.gov on the Form 8-K filed with the Securities & Exchange Commission on October 7, 2009.

John Bordynuik, JBI CEO and President, stated, “Currently, we are working to integrate the Company’s recently acquired wholly owned subsidiary Pak-It, LLC’s ‘Made In Canada’ manufacturing and marketing operations with that of JBI. Also, I am pleased that the Company is profitable in light of the recently incurred, non-recurring costs and fees associated with our

...

Helen of Troy Ltd. designs, develops and markets brand-name personal care and household consumer products. The company yesterday announced its financial results for the second quarter and half-year ended August 31, 2009, posting increases in net earnings and record sales.

The company posted second-quarter sales at $162.19 million, up 5.6 percent from $153.54 million for the second quarter of 2008. Second-quarter net earnings were $15.91 million, or $0.51 per fully diluted share, as compared to $10.60 million, or $0.34 per fully diluted share, for the same period last year.

The company reported sales for the six months ended August 31, 2009 increased 2.5 percent to $306.07 million, as compared to $298.55 million the previous year. Net earnings for the first half of this fiscal year increased 88.3 percent to $30.42 million, or $0.99 per fully diluted share, versus $16.16 million, or $0.52 per fully diluted share, in the same period

...

On a Monday afternoon, Enzon Pharmaceuticals made an announcement that FDA Oncologic Drug Advisory Committee has voted in the favor of and has approved the use of Pegintron as a treatment in addition to surgery in patients with metastatic melanoma. The news of FDA approval has boosted Enzon Pharmaceuticals and even the shares of the company have moved upwards on the market charts. The drug Pegintron is currently being manufactured, marketed and developed by Schering-Plough. The product is currently being used for the treatment of chronic hepatitis C in patients over 18 years of age.

Enzon Pharmaceuticals is a biopharmaceutical company that is dedicated to the development and commercialization of important life saving for patients who are suffering from cancer and other life threatening diseases. The FDA has approved that

...